Date:1/31/2011

ponents, and the need to comply with especially high standards for the manufacture of many of its products; the Company's ability to predict accurately the demand for its products, and products under development, and to develop strategies to address its markets successfully; the early stage of market development for certain of the Company's products; the risk of adverse events and product liability claims; risks related to the use and protection of intellectual property; expenses and uncertainties relating to litigation; technical innovations that could render products marketed or under development by the Company obsolete; competition; the risks of conducting business internationally, including the effect of exchange rate fluctuations on those operations; financing risks, including the Company's obligation to meet financial covenants under the Company's financing arrangements and leases; and the Company's ability to attract and retain qualified personnel.

The risks and uncertainties included above are not exhaustive. Other factors that could adversely affect the Company's business and prospects are described in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based. Contact:

Deborah R. Gordon Vice President, Investor RelationsHologic, Inc.(781) 999-7716HOLOGIC, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)(In thousands)December 25, 2010September 25, 2010ASSETSCURRENT ASSETS:Cash and cash equivalents

$
8,036$
515,625Restricted cash

936942Accounts receivable, net

274,437283,103Inventories

203,513192,482Deferred income tax assets

71,17572,808Prepaid expenses and other current assets

27,10333,921Total current assets

'/>"/>

SOURCE Hologic, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine technology :

1. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
2. Hologic Acquires Interlace Medical
3. Hologic to Release First Quarter Fiscal 2011 Operating Results on Monday, January 31, 2011
4. Hologic to Participate in Three Investor Conferences
5. Hologic Encourages Health Professionals to Get the Facts About Womens Imaging at RSNA 2010
6. Hologic Announces Fourth Quarter and Fiscal 2010 Operating Results
7. Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study
8. Hologic to Host Investor Presentation at RSNA 2010
9. Hologic to Release Fourth Quarter Fiscal 2010 Operating Results on Monday, November 8, 2010
10. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
11. Hologic to Present at the 2010 Morgan Stanley Global Healthcare Conference